The association between COVID-19 and atopy in Baghdad, Iraq, 2022.

Autor:	Ibrahim ZH; Specialist in Community Medicine, Iraqi Ministry of Health, Baghdad, Iraq. drziyad2005@gmail.com., Al-Diwan JK; University of Baghdad, College of Medicine, Departments of Family and Community Medicine, Iraq.
Jazyk:	angličtina
Zdroj:	The Medical journal of Malaysia [Med J Malaysia] 2023 Nov; Vol. 78 (6), pp. 717-720.
Abstrakt:	Introduction: Coronavirus disease 2019 (COVID-19) has high morbidity and mortality especially in preexisting risk groups. In atopic diseases the IgE and eosinophils are commonly elevated. This study aims to determine the potential association between COVID-19 and atopic diseases in Iraqi patients. Materials and Methods: A cross-sectional study done in Baghdad on 112 patients who attended Al-Zahraa Allergic Center. Their demographic characteristics, total IgE, eosinophil counts and PCR result for COVID-19 were determined. Results: The means for IgE and eosinophils were 245.7±260.1IU/ml and 444.5±117.1cells/microliter sequentially. Around 32.1% had high IgE level (i.e., atopic) and 11.6% had COVID-19. Among the atopic patients, 33.3%, 30.5% and 36.2% had atopic dermatitis, allergic rhinitis and asthma respectively. More than half (58.3%) of them were male, 55.5% aged <45 years, 36.2% were retired or had no job, 69.5% were graduated from secondary school or more and 88.8% lived in urban areas. There is no significant association in IgE level between those with and without COVID-19, which means that exposure to SARS Cov2 virus could not be a trigger or exacerbation for atopic diseases. Also, there was no association between atopic patients with COVID-19 and those without it regarding type of atopy, age, sex, occupation, education, type of living area. Conclusions: Atopy is not a risk factor for COVID-19.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu